| Closing Price ($) | Shares Out (MM) | Market Cap ($MM) |
| $0.00 | 0 | $0 |
| 20-F | 2019-03-31 | Annual: 2019-03-31 |
| 20-F | 2018-03-31 | Annual: 2018-03-31 |
| 20-F | 2017-03-31 | Annual: 2017-03-31 |
| 20-F | 2016-03-31 | Annual: 2016-03-31 |
| Comparables ($'000 Annual) | Ticker | Market Cap | Assets | Liabilities | Revenue | Gross Profit | Net Income | EBITDA | EV |
| Ryanair Holdings | RYAA | -0 | 13,250,700 | 8,035,800 | 0 | 0 | 0 | 0 | -34,900 |
| Lingo Media | LMDC | -0 | 1,302 | 743 | 0 | 0 | 0 | 0 | -0 |
| Apollo Education | APOL | 1,063,295 | 1,955,243 | 886,324 | 2,000,328 | 0 | -19,719 | 62,995 | 579,272 |
| China Crawfish | CACA | -0 | 2 | 0 | 0 | 0 | -4 | -4 | -3 |
| Mirenco | MREO | ||||||||
| Granite Real Estate | GRP | ||||||||
| Weyland Tech | WEYL | -0 | 10,602 | 5,280 | 29,462 | -958 | -4,242 | -4,099 | -5,303 |
| Baynon | BNON | -0 | 11 | 145 | 0 | 0 | -21 | -20 | 99 |
| Green Planet Bio Engineering | GPLB | 3,001 | 0 | 272 | 0 | 0 | -38 | -38 | 3,001 |
| G-Mes Holdings | GMES | -0 | 1,262 | 812 | 652 | 609 | 67 | 141 | -31 |
| Immune Therapeutics | IMUN | 0 | 24 | 12,553 | 0 | 34 | -5,080 | -5,079 | -21 |
| Therapeutic Solutions | TSOI | 0 | 367 | 1,851 | 13 | 10 | -1,579 | -1,236 | 481 |
| Blue Sphere | BLSP | 894 | 43,956 | 86,868 | 7,950 | 2,700 | -14,453 | -14,295 | 8,802 |
| Frontier Digital Media Group | FDMG | -0 | 5 | 31 | 32 | 0 | -29 | -29 | -3 |
| Stem Holdings | STEMH | -0 | 40,803 | 5,703 | 958 | 364 | -8,070 | -7,496 | -5,454 |
| MWF Global | MWF | -0 | -0 | -0 | 0 | 0 | -34 | -34 | -1 |
| Clean Coal Technologies | CCTC | -0 | 27 | 16,749 | 0 | 0 | -5,795 | -3,052 | 894 |
| SpringWorks | SWTX | ||||||||
| Brighthouse Life Insurance Co of Ny | BHNY | -0 | 9,065,749 | 8,029,864 | 236,819 | 0 | 0 | 2,514 | -190,199 |
| Imine | JRVS | 5,585 | 2 | 590 | 0 | 0 | -1,527 | -1,527 | 6,083 |
| Balance Sheet ($'000) | 2015-03-31 | 2016-03-31 | 2018-03-31 | 2019-03-31 |
| Cash | 1,312 | 114 | 116 | 183 |
| Accounts Receivable | 1,058 | 661 | 545 | 499 |
| Inventory | 80 | 63 | 204 | 110 |
| PP&E | 775 | 930 | 876 | 876 |
| Assets | 5,418 | 3,245 | 2,432 | 1,766 |
| Accounts Payable | 607 | 864 | 304 | 89 |
| Long-Term Debt | ||||
| Liabilities | 8,315 | 10,066 | 12,156 | 12,638 |
| Stockholders' Equity | -2,897 | -6,822 | -9,724 | -10,872 |
| Income Statement ($'000) | 2015-03-31 | 2016-03-31 | 2018-03-31 | 2019-03-31 |
| Revenue | ||||
| Cost of Revenue | ||||
| Gross Profit | ||||
| R&D | ||||
| SG&A | ||||
| Tax | ||||
| Net Income | ||||
| Cash Flow ($'000) | 2015-03-31 | 2016-03-31 | 2018-03-31 | 2019-03-31 |
| Cash Operating | ||||
| Cash Investing | ||||
| Cash Financing |